Active	Status	Sponsor type	Region	Phase	Filter
1 Active 1 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Meszoely, Ingrid
TBCRC 042, NCT02928978: Ruxolitinib for Premalignant Breast Disease	Recruiting	2	100	US	Ruxolitinib, Jakafi, INCB018424, Placebo (for Ruxolitinib)	Julie Nangia, Incyte Corporation, Translational Breast Cancer Research Consortium	Ductal Carcinoma In Situ, Atypical Lobular Hyperplasia, Atypical Ductal Hyperplasia, Lobular Carcinoma In Situ	12/24	01/25